Angela Goytain - Dissemin

Language
Login

All papers authored by Angela Goytain

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Figure S5 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Figure S3 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Data from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Tables S1-S10 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Data S1-S2 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Figure S1 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Figure S2 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karama Asleh, Ana Lluch, Angela Goytain

ORCID

, Carlos Barrios, Xue Q. Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz-Borrego, Samuel Leung, José Bines, Ángel Guerrero-Zotano, Jose Ángel García-Sáenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres and 6 other authors

Supplementary Figure S4 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Karama Asleh

ORCID

ORCID

, Angela Goytain

ORCID

, Carlos Barrios

ORCID

ORCID

, Laura Torrecillas

ORCID

ORCID

, Manuel Ruiz-Borrego

ORCID

ORCID

ORCID

, Ángel Guerrero-Zotano

ORCID

, Jose Ángel García-Sáenz

ORCID

, Juan Miguel Cejalvo

ORCID

, Jesus Herranz

ORCID

, Roberto Torres

ORCID

and 6 other authors

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

Upload

Missing publications? Search for publications with a matching author name.